COMPANY
SEACROSS PHARMA USA INC
SEACROSS PHARMA USA INC: API manufacturer for Carfilzomib, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Carfilzomib | DMF 38169, type II, inactive, submitted 2023-04-03 Regulator FDA drug master file list |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.